Clinical Trials
10 trialsNCT04731844 2026-05-12
Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer
University of Rochester
Phase 2 Completed
NCT02064673 2026-03-30
Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy
University of Texas Southwestern Medical Center
Phase 3 Recruiting
NCT06044025 2026-01-15
A Feasibility Study Evaluating a Role for Maintenance Therapy in Patients With Biochemically Progressive Castration Sensitive Prostate Cancer on Intermittent Androgen Deprivation Therapy
University of Arkansas
Phase 1 Recruiting
NCT03769766 2025-06-11
Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance
University of Texas Southwestern Medical Center
Phase 3 Recruiting
NCT04403568 2021-09-16
Testing the Synergism of Phytonutrients, Curcumin and Ursolic Acid, to Target Molecular Pathways in the Prostate
The University of Texas Health Science Center at San Antonio
Phase EARLY_PHASE1 Withdrawn
NCT03290417 2020-02-18
Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer
Case Comprehensive Cancer Center
Phase NA Completed
NCT02095717 2018-07-24
CURTAXEL
Centre Jean Perrin
Phase 2 Terminated
NCT02724618 2017-10-12
Nanocurcumin for Prostate Cancer Patients Undergoing Radiotherapy (RT)
Shahid Beheshti University of Medical Sciences
Phase 2 Unknown
NCT03211104 2017-07-07
Comparison of Duration of Treatment Interruption With or Without Curcumin During the Off Treatment Periods in Patients With Prostate Cancer Undergoing Intermittent Androgen Deprivation Therapy
Samsung Medical Center
Phase NA Completed
NCT01917890 2015-11-18
Radiosensitizing and Radioprotectve Effects of Curcumin in Prostate Cancer
Shahid Beheshti University of Medical Sciences
Phase NA Completed